l9n/ Pennsylvania

2017–2018 Regular Session

House Bill 932

An Act providing for licensure of buprenorphine office-based prescribers; limiting the use of buprenorphine; and establishing penalties.

Did not become law. It stopped in the House of Representatives's Human Services Committee on March 23, 2017. The 2017–2018 session has ended.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

In the House of Representatives

13 co-sponsors

THOMAS P. MURT, Michael J. Driscoll, DOMINIC J. COSTA, EDDIE DAY PASHINSKI, JOHN J. TAYLOR, Dan L. Miller, Matthew D. Dowling, TINA M. DAVIS, McNEILL, C. ADAM HARRIS, ANTHONY M. DELUCA, THOMAS R. CALTAGIRONE, MARIA P. DONATUCCI

Its course

March 23 to March 23, 2017, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

Each committee stop sits inside its chamber.

Every action1 action on 1 day

In the House of RepresentativesMar 23 to Mar 23 · stopped0 days

Human ServicesMar 23 to Mar 23 · stopped0 days

Text

Each version as the General Assembly printed it.

l9n doesn't hold this bill's text yet.

What happened

In l9n's words, one line for each step. Every action as the General Assembly published it is below.

In the House of Representatives Mar 23

  1. Mar 23Sent to HUMAN SERVICES
All 1 actions, as published
  1. Mar 23Referred to HUMAN SERVICES, March 23, 2017 [House]House of Representatives